Experience of conducting a phase I safety & acceptability clinical trial of a candidate vaginal microbicide & lessons learned

Translate this page into:

Correspondence

128 (

2

); 212-213

doi:

10.25259/IJMR_20081282_212

Soma Dutta^*,†, Neelam Joglekar^*, Smita Joshi^*, J. Reynolds Steven^**

*National AIDS Research Institute G-73, MIDC, Post Box 1895, Bhosari, Pune 411 026, India

**The National Institute of Allergy & Infectious Diseases National Institutes of Health (NIH) & Johns Hopkins University School of Medicine, USA

†For correspondence: seeksoma@rediffmail.com

Licence

This open access article is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). http://creativecommons.org/licenses/by/4.0

Fulltext Views
180

PDF downloads
41

View/Download PDF
Download Citations

BibTeX
RIS